Advertisement

Table of Contents

March 01, 1996; Volume 49,Issue 3

You have access
Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.
J M Rimland, E P Seward, Y Humbert, E Ratti, D G Trist and R A North

Molecular Pharmacology March 1996, 49 (3) 387-390;
You have access
The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
R S Pollenz

Molecular Pharmacology March 1996, 49 (3) 391-398;
You have access
Epidermal growth factor-mediated inhibition of neurotransmitter glutamate release from rat forebrain synaptosomes.
A Barrie, E Chieregatti, M Miloso, F Benfenati and F Valtorta

Molecular Pharmacology March 1996, 49 (3) 399-403;
You have access
Role of Cu/Zn-superoxide dismutase in xenobiotic activation. I. Chemical reactions involved in the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
Y Li, P Kuppusamy, J L Zweier and M A Trush

Molecular Pharmacology March 1996, 49 (3) 404-411;
You have access
Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
Y Li, P Kuppusamy, J L Zweir and M A Trush

Molecular Pharmacology March 1996, 49 (3) 412-421;
You have access
Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity.
L Prézeau, J Gomeza, S Ahern, S Mary, T Galvez, J Bockaert and J P Pin

Molecular Pharmacology March 1996, 49 (3) 422-429;
You have access
Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
E A Ercikan-Abali, M C Waltham, A P Dicker, B I Schweitzer, H Gritsman, D Banerjee and J R Bertino

Molecular Pharmacology March 1996, 49 (3) 430-437;
You have access
Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors.
A M Garland, E F Grady, M Lovett, S R Vigna, M M Frucht, J E Krause and N W Bunnett

Molecular Pharmacology March 1996, 49 (3) 438-446;
You have access
Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway.
F Sugawara, H Ninomiya, Y Okamoto, S Miwa, O Mazda, Y Katsura and T Masaki

Molecular Pharmacology March 1996, 49 (3) 447-457;
You have access
Expression and zonal distribution of CYP2D16 in the guinea pig adrenal cortex: relationship to xenobiotic metabolism.
Q Jiang, Y Huang, J M Voigt, B K DeBolt, S Kominami, S Takemori, Y Funae and H D Colby

Molecular Pharmacology March 1996, 49 (3) 458-464;
You have access
Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).
L A Dowd, A J Coyle, J D Rothstein, D B Pritchett and M B Robinson

Molecular Pharmacology March 1996, 49 (3) 465-473;
You have access
Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division.
R S Westphal and E Sanders-Bush

Molecular Pharmacology March 1996, 49 (3) 474-480;
You have access
Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
V Contesse, C Hamel, H Lefebvre, A Dumuis, H Vaudry and C Delarue

Molecular Pharmacology March 1996, 49 (3) 481-493;
You have access
Homomeric beta 1 gamma-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties.
B J Krishek, S J Moss and T G Smart

Molecular Pharmacology March 1996, 49 (3) 494-504;
You have access
Gastrin-releasing peptide receptor signaling resulting in growth inhibition.
R I Feldman, S Fried, E Mann, J M Wu and M Liang

Molecular Pharmacology March 1996, 49 (3) 505-514;
You have access
Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
G M Raner, A D Vaz and M J Coon

Molecular Pharmacology March 1996, 49 (3) 515-522;
You have access
Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose.
A K Agrawal and B H Shapiro

Molecular Pharmacology March 1996, 49 (3) 523-531;
You have access
Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
S Mankhetkorn, F Dubru, J Hesschenbrouck, M Fiallo and A Garnier-Suillerot

Molecular Pharmacology March 1996, 49 (3) 532-539;
You have access
Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors.
T J Wilding and J E Huettner

Molecular Pharmacology March 1996, 49 (3) 540-546;
You have access
N-[5-nitro-2-furfurylidene]-3-amino-2-oxazolidinone activation by the human intestinal cell line Caco-2 monitored through noninvasive electron spin resonance spectroscopy.
L Rossi, I De Angelis, J Z Pedersen, E Marchese, A Stammati, G Rotilio and F Zucco

Molecular Pharmacology March 1996, 49 (3) 547-555;
You have access
Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
M Gobbi, L Parotti and T Mennini

Molecular Pharmacology March 1996, 49 (3) 556-559;
You have access
Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami and H Hamaguchi

Molecular Pharmacology March 1996, 49 (3) 560-566;
You have access
Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms.
N C Saxena and R L Macdonald

Molecular Pharmacology March 1996, 49 (3) 567-579;